Can the Toll-like receptors 4 expression in peripheral blood mononuclear cells help assess the effectiveness of immunosuppression and the chance of a future good renal transplant function?

• Published in: Transplant immunology Vol. 53; pp. 43 - 50
• Main Authors: Zmonarski, Slawomir C., Madziarska, Katarzyna, Golebiowski, Tomasz, Banasik, Miroslaw, Mazanowska, Oktawia, Madziarski, Marcin, Krajewska, Magdalena
• Format: Journal Article
• Language: English
• Published: Netherlands Elsevier B.V 01-04-2019
• Subjects: Delayed graft function; Kidney transplant; Peripheral blood mononuclear cells; Toll-like receptors 4 expression; Toll-like receptors 4 expression; Peripheral blood mononuclear cells; Kidney transplant; Delayed graft function
• ISSN: 0966-3274; 1878-5492
• DOI: 10.1016/j.trim.2018.12.005

A small percentage of peripheral blood mononuclear cells (PBMCs) circulating during the kidney transplantation (KT) period remain in the blood long after transplantation. A part of the PBMCs penetrates the graft.
To examine if the choice of immunosuppression may change TLR4ex and how TLR4ex affects the transplant function in the future.
The study population-143 transplanted patients (pts) (55 females, 88 males), mean age on recruitment day 50.33 ± 12.8 years old, mean BMI 25.04 ± 4.18. 41 pts. experienced delayed graft function (DGF+). 55 pts. were treated with cyclosporine A (CsA) and 88 with tacrolimus (Tac). All were treated with mofetil mycophenolate (MMF). The PBMCs acquisition and starting point of the follow-up (TLR-day) was at least one month after KT.
We investigated averaged mRNA expression of Toll-like receptors 4 (TLR4ex) in non-stimulated peripheral blood mononuclear cells with the use of real-time polymerase chain reaction. The KT pts. (All, Tac, CsA, DGF+) were divided by the respective median of their TLR4ex (lower: L-TLR4ex, higher: H-TLR4ex). Main clinical parameters and transplant biopsy files (if available) were assessed on TLR-day and post follow-up.
We found that TLR4ex was reduced for a long time in patients who experienced delayed graft function. L-TLR4ex had a higher proportion of DGF+ patients, and patients treated with CsA but lower of those treated with Tac than in H-TLR4ex. The amplitude of changes in renal function parameters (ΔEGFR%/ΔsCr/ΔsCr%) was clearly less favorable for L-TLR4ex. Tacrolimus expressed a stabilizing effect. Both the positive vasculitis score and chronic graft nephropathy were more frequent in the L-TLR4ex group. On TLR-day an association of renal function and Tac concentration with TLR4ex was clear only in the tacrolimus population. The TLR4ex was lower in patients with a future deterioration of the graft function.
In kidney transplant recipients the occurrence of DGF results in a long-term reduction of the averaged TLR4ex in PBMC. Tacrolimus exerts a clear, stabilizing, positive and dose-dependent effect on TLR4ex. An improvement in renal transplant function may be expected in KT patients with high TLR4ex. Evaluation of the averaged TLR4ex can be used to assess the efficacy of immunosuppression in the treatment with tacrolimus and to estimate the likelihood of deterioration in renal function.
•Tacrolimus exerts a clear, stabilizing, positive and dose-dependent effect on Toll-like receptors 4 (TLR4ex)•In kidney transplant delayed graft function reduces expression of TLR4ex in peripheral blood mononuclear cells•An improvement in renal transplant function may be expected in kidney transplantation  patients with high TLR4ex•Evaluation of TLR4ex can assess the efficacy of tacrolimus and to estimate the likelihood of deterioration in renal function